Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 18 drugs
No. | KEGG DRUG | DrugBank | Drug (Description in trials) | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
Oxygen
1. Oxygen
| [1] Oxygen Oxygen | [3] Medical air Medical air; Nitrogen; OXYGEN | - | - | [13] 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬1. Oxygen
| ||||||||||||||||||||||||||||||||||||||||||||||||
2 |
Glucose
2. Glucose
| [1] D-glucose D-glucose | [2] D-glucose D-glucose; Glucose | - | - | [3] 49 49, 86, 88 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
3 |
Nitric oxide
3. Nitric oxide
| [1] Nitric Oxide Nitric Oxide | [3] INOmax INOmax; Nitric Oxide; Nitrosyl | - | - | [7] 85 85, 86, 88, 210, 251, 294, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
4 |
Bosentan
4. Bosentan
| [1] Bosentan Bosentan | [2] Bosentan Bosentan; TRACLEER | [2] EDNRA EDNRA,EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
5 |
Fludeoxyglucose F 18
5. Fludeoxyglucose F 18
| [1] Fludeoxyglucose Fludeoxyglucose | [1] Fludeoxyglucose Fludeoxyglucose | - | - | [3] 84 84, 85, 88 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
6 |
Treprostinil
6. Treprostinil
| [1] Treprostinil Treprostinil | [4] Remodulin Remodulin; Treprostinil; Treprostinilo; Tyvaso | [1] PTGIR PTGIR 💬6. Treprostinil
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | [6] 51 51, 84, 85, 86, 88, 210 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
7 |
Ambrisentan
7. Ambrisentan
| [1] Ambrisentan Ambrisentan | [3] AMBRISENTAN AMBRISENTAN; Letairis; VOLIBRIS | [1] EDNRA EDNRA 💬7. Ambrisentan
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | [7] 51 51, 84, 85, 86, 88, 210, 211 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
8 |
Atorvastatin
8. Atorvastatin
| [1] Atorvastatin Atorvastatin | [3] Atorvastatin Atorvastatin; Atorvastatin calcium; Lipitor | [1] HMGCR HMGCR 💬8. Atorvastatin
| [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [19] 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬8. Atorvastatin
| ||||||||||||||||||||||||||||||||||||||||||||||||
9 |
Bosentan
9. Bosentan
| [1] Bosentan Bosentan | [2] Bosentan Bosentan; TRACLEER | [2] EDNRA EDNRA,EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
10 |
Gadobenic acid
10. Gadobenic acid
| [1] Gadobenic acid Gadobenic acid | [2] Gadobenate Gadobenate; MultiHance | - | - | [3] 13 13, 86, 88 💬
|